SANUWAVE Health Inc. Announces Separation Agreement with Former Chief Commercial Officer, Including Cash Payment and Stock Option Vesting

Reuters
01 Aug
<a href="https://laohu8.com/S/SNWV">SANUWAVE Health</a> Inc. Announces Separation Agreement with Former Chief Commercial Officer, Including Cash Payment and Stock Option Vesting

SANUWAVE Health Inc. has announced a new compensation agreement following the termination of Nanci Gilmore, the company's former Chief Commercial Officer. As part of a Separation and Release Agreement dated July 28, 2025, Ms. Gilmore will receive a lump sum cash payment totaling $112,707.51, which includes five months' annual base salary and a pro-rated bonus. Additionally, her employee stock options will continue to vest through January 31, 2026, and remain exercisable until their expiration dates. The agreement also includes standard confidentiality and non-disparagement clauses.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-037048), on July 31, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10